Dr. Weidhaas comes to UCLA from Yale Cancer Center where she has specialized in women's health, as head of the Breast and Gynecological services during her tenure there. She has successfully sustained NIH grant funding in microRNAs, and her laboratory works to best define the applications of microRNAs in personalized medicine. Dr. Weidhaas is a leader in translational research and holds several patents, is a co-founder of MiraDX, a molecular diagnostics company, and a founder of MiraKind, a non-profit focused on advancing the application of microRNA discoveries for cancer prevention. She is a frequently invited speaker to medical conferences throughout the world. Dr. Weidhaas attended Yale University as an undergraduate, Tufts Medical School to earn her MDPhD, completed residency training at Memorial Sloan-Kettering Cancer Center, and most recently earned a Masters in Business Management at the Stanford Business School.